home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

181 rows where in_cev_map = 1, surface_class = "A2_pm_peripheral" and tier = "Tier 1" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: aptamer_count_pubmed

has_structure 2

  • 1 170
  • 0 11

has_known_aptamer 2

  • 0 121
  • 1 60

has_cryoEM 2

  • 0 142
  • 1 39

has_activation_state_pdb_pair 2

  • 0 179
  • 1 2

tier 1

  • Tier 1 · 181 ✖

surface_class 1

  • A2_pm_peripheral · 181 ✖

in_cev_map 1

  • 1 · 181 ✖
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P35555 FBN1 Fibrillin-1 Tier 1 0.809 1 A2_pm_peripheral 11   0 0     0 0   1 Marfan syndrome 0.8969300970597663
P15056 BRAF Serine/threonine-protein kinase B-raf Tier 1 0.803 1 A2_pm_peripheral 100 66.38 0 0     1 6 39624124, 34874026, 33497198, 31726389, 24486214, 11856330 1 cardiofaciocutaneous syndrome 0.8764542776642054
P04049 RAF1 RAF proto-oncogene serine/threonine-protein kinase Tier 1 0.799 1 A2_pm_peripheral 75 67.5 0 0     1 4 15112994, 12173045, 11856330, 9883908 1 Noonan syndrome 0.8625147809861142
P51531 SMARCA2 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 Tier 1 0.797 1 A2_pm_peripheral 31 65.06 0 0     0 0   1 intellectual disability-sparse hair-brachydactyly syndrome 0.85547142397368
P62873 GNB1 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 Tier 1 0.794 1 A2_pm_peripheral 100 97.06 1 0     0 0   1 intellectual disability, autosomal dominant 42 0.8462216225099116
P52333 JAK3 Tyrosine-protein kinase JAK3 Tier 1 0.794 1 A2_pm_peripheral 42 85.69 0 0     0 0   1 T-B+ severe combined immunodeficiency due to JAK3 deficiency 0.8450717197794638
Q06187 BTK Tyrosine-protein kinase BTK Tier 1 0.794 1 A2_pm_peripheral 100 84.44 0 0     1 1 41951939 1 X-linked agammaglobulinemia 0.8454716106068291
Q02750 MAP2K1 Dual specificity mitogen-activated protein kinase kinase 1 Tier 1 0.788 1 A2_pm_peripheral 94 83.25 0 0     1 1 29580944 1 cardiofaciocutaneous syndrome 0.825549979325162
O75369 FLNB Filamin-B Tier 1 0.788 1 A2_pm_peripheral 23 76.25 0 0     0 0   1 Larsen syndrome 0.826975893141549
P06737 PYGL Glycogen phosphorylase, liver form Tier 1 0.787 1 A2_pm_peripheral 19 92.69 1 0     0 0   1 glycogen storage disease VI 0.8220063508118274
P49770 EIF2B2 Translation initiation factor eIF2B subunit beta Tier 1 0.787 1 A2_pm_peripheral 25 86.56 1 0     0 0   1 CACH syndrome 0.824634396744653
P21333 FLNA Filamin-A Tier 1 0.786 1 A2_pm_peripheral 26 76.56 1 0     0 0   1 Melnick-Needles syndrome 0.8200516896124751
O43175 PHGDH D-3-phosphoglycerate dehydrogenase Tier 1 0.784 1 A2_pm_peripheral 21 92.94 0 0     0 0   1 PHGDH deficiency 0.8128323162948055
P01111 NRAS GTPase NRas Tier 1 0.783 1 A2_pm_peripheral 35 92.06 0 0     1 2 39952900, 39371477 1 Noonan syndrome 6 0.8087775198380727
Q9Y3Z3 SAMHD1 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Tier 1 0.783 1 A2_pm_peripheral 76 88.19 0 0     0 0   1 Aicardi-Goutières syndrome 0.8101030032946703
Q8TD16 BICD2 Protein bicaudal D homolog 2 Tier 1 0.782 1 A2_pm_peripheral 2 78.0 0 0     0 0   1 autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures 0.8072433385790271
Q08499 PDE4D 3',5'-cyclic-AMP phosphodiesterase 4D Tier 1 0.782 1 A2_pm_peripheral 100 67.44 0 0     0 0   1 acrodysostosis 2 with or without hormone resistance 0.8053064772512085
Q01831 XPC DNA repair protein complementing XP-C cells Tier 1 0.782 1 A2_pm_peripheral 14 66.56 1 0     0 0   1 Xeroderma pigmentosum complementation group C 0.8056391472748724
Q96BN8 OTULIN Ubiquitin thioesterase otulin Tier 1 0.781 1 A2_pm_peripheral 12 83.81 0 0     0 0   1 autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive 0.804614072482804
O60674 JAK2 Tyrosine-protein kinase JAK2 Tier 1 0.78 1 A2_pm_peripheral 100 86.88 0 0     1 8 41455398, 34121564, 32985358, 31279934, 30415442, 25809097, 22411871, 20711698 1 polycythemia vera 0.8000866241942614
P01137 TGFB1 Transforming growth factor beta-1 proprotein Tier 1 0.78 1 A2_pm_peripheral 20 79.56 1 0     1 4 38132522, 32370304, 16775010, 11856769 1 Camurati-Engelmann disease 0.7995305374459716
P98170 XIAP E3 ubiquitin-protein ligase XIAP Tier 1 0.78 1 A2_pm_peripheral 74 74.25 0 0     1 4 35383192, 29864441, 27514505, 26318819 1 X-linked lymphoproliferative disease 0.8013347966323413
Q9UHD9 UBQLN2 Ubiquilin-2 Tier 1 0.778 1 A2_pm_peripheral 4 61.03 0 0     1 2 23541532 1 amyotrophic lateral sclerosis type 15 0.7942015735994536
P49773 HINT1 Adenosine 5'-monophosphoramidase HINT1 Tier 1 0.777 1 A2_pm_peripheral 59 96.19 0 0     0 0   1 Autosomal recessive axonal neuropathy with neuromyotonia 0.7895184274923306
O15294 OGT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit Tier 1 0.77 1 A2_pm_peripheral 44 93.06 0 0     1 2 36868188, 36626902 1 intellectual disability, X-linked 106 0.7660009745204424
Q9Y263 PLAA Phospholipase A-2-activating protein Tier 1 0.77 1 A2_pm_peripheral 5 84.0 0 0     0 0   1 neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 0.7656265019633831
Q9NWZ3 IRAK4 Interleukin-1 receptor-associated kinase 4 Tier 1 0.768 1 A2_pm_peripheral 96 83.94 0 0     0 0   1 immunodeficiency 67 0.7593923638641371
Q92743 HTRA1 Serine protease HTRA1 Tier 1 0.768 1 A2_pm_peripheral 18 83.25 1 0     1 1 31988066 1 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 0.7611877816680132
Q9BYI3 HYCC1 Hyccin Tier 1 0.766 1 A2_pm_peripheral 5 67.75 1 0     0 0   1 Hypomyelination - congenital cataract 0.7528702184568328
P35221 CTNNA1 Catenin alpha-1 Tier 1 0.765 1 A2_pm_peripheral 10 82.94 1 0     1 2 40265971 1 Butterfly-shaped pigment dystrophy 0.7487735496199569
Q01484 ANK2 Ankyrin-2 Tier 1 0.762 1 A2_pm_peripheral 11 61.78 0 0     0 0   1 Romano-Ward syndrome 0.7390647393986454
P13797 PLS3 Plastin-3 Tier 1 0.757 1 A2_pm_peripheral 6 88.75 1 0     0 0   1 X-linked osteoporosis with fractures 0.721756781312783
P26038 MSN Moesin Tier 1 0.755 1 A2_pm_peripheral 10 86.38 0 0     1 65 41813080, 41784619, 41611946, 40904334, 40886652, 40258621, 40222299, 39454415, 39053429, 38856817, 38759442, 38687941, 38561432, 38446130, 38349197, 38295649, 38266273, 37869770, 37806507, 37423650, 37353120, 37062561, 37058944, 36982925, 36843953, 36700559, 36562728, 36179642, 35026109, 34893239, 34538325, 33960345, 33727809, 33528465, 33149582, 32882423, 32291531, 32170403, 31872318, 31792209, 31213813, 31072481, 30985076, 30865739, 32254866, 29955964, 29568450, 29136862, 28917759, 28832225 1 combined immunodeficiency due to moesin deficiency 0.7157135146765757
P84077 ARF1 ADP-ribosylation factor 1 Tier 1 0.755 1 A2_pm_peripheral 36 85.94 1 0     1 3 30965174, 11320245 1 periventricular nodular heterotopia 8 0.7173626622431929
P07948 LYN Tyrosine-protein kinase Lyn Tier 1 0.754 1 A2_pm_peripheral 6 83.12 0 0     0 0   1 autoinflammatory disease, systemic, with vasculitis 0.7119500711989845
Q13153 PAK1 Serine/threonine-protein kinase PAK 1 Tier 1 0.753 1 A2_pm_peripheral 41 73.69 0 0     1 2 32636813, 20564698 1 intellectual developmental disorder with macrocephaly, seizures, and speech delay 0.7110292416229067
O15117 FYB1 FYN-binding protein 1 Tier 1 0.752 1 A2_pm_peripheral 3 56.59 0 0     0 0   1 thrombocytopenia 3 0.7067701415491194
P07357 C8A Complement component C8 alpha chain Tier 1 0.75 1 A2_pm_peripheral 11 78.69 1 0     0 0   1 Immunodeficiency due to a late component of complements deficiency 0.700643416115894
Q13546 RIPK1 Receptor-interacting serine/threonine-protein kinase 1 Tier 1 0.749 1 A2_pm_peripheral 39 69.75 1 0     1 2 41290466, 35919280 1 immunodeficiency 57 0.698121745966467
Q9Y5K6 CD2AP CD2-associated protein Tier 1 0.749 1 A2_pm_peripheral 12 62.22 0 0     0 0   1 focal segmental glomerulosclerosis 0.6952333377860125
P50148 GNAQ Guanine nucleotide-binding protein G(q) subunit alpha Tier 1 0.748 1 A2_pm_peripheral 30 93.0 1 0     1 1 40015005 1 Sturge-Weber syndrome 0.6941111530708174
Q8IZQ1 WDFY3 WD repeat and FYVE domain-containing protein 3 Tier 1 0.748 1 A2_pm_peripheral 2   0 0     0 0   1 Autosomal dominant microcephaly 0.6934322596452817
P61586 RHOA Transforming protein RhoA Tier 1 0.744 1 A2_pm_peripheral 100 93.56 0 0     1 4 25645980, 19389625, 12927206, 12123800 1 ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies 0.6804889074382072
Q00535 CDK5 Cyclin-dependent kinase 5 Tier 1 0.744 1 A2_pm_peripheral 10 91.56 0 0     1 4 33291667, 33200349 1 Alzheimer disease 0.6800338890220147
Q96CW1 AP2M1 AP-2 complex subunit mu Tier 1 0.741 1 A2_pm_peripheral 4 89.19 0 0     0 0   1 intellectual developmental disorder 60 with seizures 0.6712897942723018
O95786 RIGI Antiviral innate immune response receptor RIG-I Tier 1 0.735 1 A2_pm_peripheral 44 85.19 1 0     1 6 34487794, 33253193, 32946572, 31600868, 26018150, 22127865 1 Singleton-Merten dysplasia 0.6485708110478319
P26196 DDX6 Probable ATP-dependent RNA helicase DDX6 Tier 1 0.734 1 A2_pm_peripheral 9 84.06 0 0     1 2 34132569 1 intellectual developmental disorder with impaired language and dysmorphic facies 0.6482686715821397
P48730 CSNK1D Casein kinase I isoform delta Tier 1 0.732 1 A2_pm_peripheral 46 81.0 0 0     0 0   1 Familial advanced sleep-phase syndrome 0.6394614732145313
P27815 PDE4A 3',5'-cyclic-AMP phosphodiesterase 4A Tier 1 0.732 1 A2_pm_peripheral 5 64.5 0 0     0 0   1 psoriasis 0.6394621747004946
P12931 SRC Proto-oncogene tyrosine-protein kinase Src Tier 1 0.73 1 A2_pm_peripheral 78 83.44 0 1 1Y57 2SRC 1 19 40569566, 39664567, 38471488, 35928129, 35859339, 34757788, 34083659, 33530373, 32668060, 30970280, 28701145, 26458993, 25645980, 23842900, 22693611, 22323540, 18985031, 18682833, 12842895 1 cancer 0.6343904000453656

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 907.134ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target